(Q40162233)

18 September 2017

1 reference

title

Remission-inducing therapy in rheumatoid arthritis (English)

1 reference

18 September 2017

0 references

P. E. Lipsky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6356907

6 October 2023

language of work or name

English

0 references

publication date

1 October 1983

1 reference

18 September 2017

31 October 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6356907

full work available at URL

6 October 2023

https://api.elsevier.com/content/article/PII:0002934383903273?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

https://api.elsevier.com/content/article/PII:0002934383903273?httpAccept=text/plain

6 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

American Journal of Medicine

6 October 2023

published in

1 reference

18 September 2017

volume

75

1 reference

18 September 2017

issue

4B

1 reference

18 September 2017

page(s)

40-49

1 reference

Course and prognosis in rheumatoid arthritis

18 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Drug therapy: nonsteroidal antiinflammatory drugs (first of two parts).

6 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Do drugs change the course of rheumatoid arthritis?

6 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Preliminary criteria for clinical remission in rheumatoid arthritis

6 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Articular erosions in rheumatoid arthritis

6 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Gold salts in the treatment of rheumatoid arthritis. A double-blind study

6 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

A Controlled Trial of Cyclophosphamide in Rheumatoid Arthritis

6 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.

6 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

OBSERVATIONS ON THE CLINICAL, CHEMICAL, AND SEROLOGICAL MANIFESTATIONS OF RHEUMATOID ARTHRITIS, BASED ON THE COURSE OF 154 CASES

6 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Significance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. A follow-up study

6 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes

6 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Gold Therapy in Rheumatoid Arthritis: Final Report of a Multicentre Controlled Trial

6 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Chloroquine diphosphate in rheumatoid arthritis. A controlled trial

6 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis

6 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

A multicentre randomized double-blind study comparing two dosages of levamisole in rheumatoid arthritis

6 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis

6 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

A biochemical comparison of alclofenac and D-penicillamine in rheumatoid arthritis

6 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

EMPIRE Rheumatism Council: multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis; results of three years' treatment

6 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Chrysotherapy in psoriatic arthritis. Efficacy and toxicity compared to rheumatoid arthritis

6 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Gold sodium thiomalate treatment of pemphigus

6 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis

6 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

SALICYLATE THERAPY IN RHEUMATOID ARTHRITIS

6 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

6 October 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year

6 October 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Evidence that D-penicillamine alters the course of rheumatoid arthritis

6 October 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

The immunopathology of joint inflammation in rheumatoid arthritis

6 October 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

In vitro synthesis of immunoglobulin by rheumatoid synovial membrane

6 October 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Predominantly T-Cell Infiltrate in Rheumatoid Synovial Membranes

6 October 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Lymphokines in the rheumatoid joint

6 October 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Ia+ T cells in synovial fluid and tissues of patients with rheumatoid arthritis

6 October 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

THE SUPPRESSION OF IMMUNOLOGIC ACTIVITY BY DIVERSION OF THORACIC DUCT LYMPH

6 October 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Fistula of the thoracic duct as immunosuppressive treatment in rheumatoid arthritis

6 October 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage

6 October 2023

46

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Plasmapheresis and lymphoplasmapheresis in the management of rheumatoid arthritis

6 October 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Lymphapheresis in rheumatoid arthritis. A randomized trial

6 October 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Treatment of intractable rheumatoid arthritis with total lymphoid irradiation

6 October 2023

49

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis

6 October 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

The effect of gold salt on lysosomal enzymes of the peritoneal macrophage

6 October 2023

52

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Effect of gold salts and other drugs on the release and activity of lysosomal hydrolases

6 October 2023

53

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Inhibition of adenosine triphosphatases by gold

6 October 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Inhibition of the alternative pathway of complement by gold sodium thiomalate in vitro

6 October 2023

56

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Inhibition of prostaglandin synthesis and human epidermal enzymes by aurothiomalate in vitro: possible actions of gold in pemphigus.

6 October 2023

57

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Selective inhibition of prostaglandin biosynthesis by gold salts and phenylbutazone

6 October 2023

58

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Investigations on the reaction of metals with collagen in vivo. 1. Comparison of the reaction of gold thiosulphate with collagen in vivo and vitro

6 October 2023

59

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Effect of anti-arthritic drugs on sulfhydryl reactivity of rat serum

6 October 2023

62

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Action of gold salts on the inflammatory response and inflammatory cell function

6 October 2023

63

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Chrysotherapy. suppression of immunoglobulin synthesis

6 October 2023

64

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Effect of gold salts and antimalarials on the rheumatoid factor in rheumatoid arthritis

6 October 2023

65

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds

6 October 2023

67

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Alterations in human monocyte structure and function induced by incubation with gold sodium thiomalate

6 October 2023

68

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Gold-induced changes in the morphology and functional capabilities of human monocytes

6 October 2023

69

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Tissue gold concentration in a rheumatoid arthritic receiving chrysotherapy

6 October 2023

71

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Selective concentration and localization of gold in macrophages of synovial and other tissues during and after chrysotherapy in rheumatoid patients

6 October 2023

72

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Electron-dense deposits following injection of Gold Sodium Thiomalate and Thiomalic acid

6 October 2023

73

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Ultrastructural changes produced in rheumatoid synovial membrane by chrysotherapy

6 October 2023

75

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Localization of gold in synovial membrane of rheumatoid arthritis treated with sodium aurothiomalate. Studies by electron microscope and electron probe x-ray microanalysis

6 October 2023

76

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Effects of gold salts and prednisolone on inflammatory cells. II. Suppression of inflammation and phagocytosis in the rat

6 October 2023

77

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Effects of gold salts and prednisolone on inflammatory cells. I. Phagocytic activity of macrophages and polymorphs in inflammatory exudates studied by a "skin-window" technique in rheumatoid and control patients

6 October 2023

78

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Treatment of lupus erythematosus with mepacrine

6 October 2023

79

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

A controlled study of chloroquine as an antirheumatic agent

6 October 2023

80

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Chloroquine treatment and bone changes in rheumatoid arthritis

6 October 2023

82

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Azathioprine in early rheumatoid arthritis. Comparison with gold and chloroquine

6 October 2023

83

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Antimalarial Treatment of Rheumatoid Arthritis

6 October 2023

84

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

SUPPRESSION OF IN VITRO LYMPHOCYTE RESPONSES BY CHLOROQUINE.

6 October 2023

85

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Action of chloroquine phosphate in rheumatoid arthritis. 1. Immunosuppressive effect

6 October 2023

86

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Autophagic vacuoles produced in vitro. I. Studies on cultured macrophages exposed to chloroquine

6 October 2023

87

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

The effect of immunosuppressive and anti-inflammatory drugs on monocyte function in vitro

6 October 2023

88

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Penicillamine, a Characteristic Degradation Product of Penicillin

6 October 2023

91

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Intra-articular dissociation of the rheumatoid factor

6 October 2023

95

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Comparison of the effect of plasmapheresis and penicillamine on the level of circulating rheumatoid factor

6 October 2023

96

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

RHEUMATOID ARTHRITIS WITH ARTERITIS; REPORT OF A CASE TREATED WITH PENICILLAMINE.

6 October 2023

97

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen

6 October 2023

98

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial

6 October 2023

99

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Controlled trial of D-penicillamine in rheumatoid arthritis. Dose effect and the role of zinc

6 October 2023

100

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis

6 October 2023

101

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

The effect of penicillamine on the laboratory parameters in rheumatoid arthritis

6 October 2023

102

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Penicillamine in rheumatoid arthritis

6 October 2023

103

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Determination of d-penicillamine in serum and urine of patients with rheumatoid arthritis

6 October 2023

104

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Effects of oral cysteine, penicillamine and N-acetyl-penicillamine on adjuvant arthritis in rats

6 October 2023

106

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Failure of oral D-penicillamine to modify adjuvant arthritis or immune response in the rat

6 October 2023

107

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Copper chelates as possible active forms of the antiarthritic agents

6 October 2023

109

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Pertussis vaccine oedema: an experimental model for the action of penicillamine-like drugs

6 October 2023

110

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Superoxide dismutase activity of copper-penicillamine: possible involvement of Cu(I) stabilized sulphur radical

6 October 2023

112

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor

6 October 2023

113

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Some immunological changes in rheumatoid arthritis among patients receiving penicillamine and gold

6 October 2023

114

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Effect of penicillamine therapy on circulating immune complexes in rheumatoid arthritis

6 October 2023

115

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Influence of D-penicillamine on the immune response of mice

6 October 2023

119

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4

6 October 2023

123

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

5-thiopyridoxine in rheumatoid arthritis: clinical and experimental studies

6 October 2023

127

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

An assessment of penicillamine therapy in rheumatoid arthritis and the influence of previous gold therapy

6 October 2023

128

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

Does the order of second-line treatment in rheumatoid arthritis matter?

6 October 2023

129

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90327-3

6 October 2023

Identifiers

1 reference

18 September 2017

1 reference